BioMark Diagnostics announces uplisting to OTCQB venture market BioMark Diagnostics announces uplisting to OTCQB venture market Post ContentbmkdfRead More You might also be interested in reading A2Z Cust2Mate Solutions prices $30M stock offering. May 8, 2025 In Mainstream ← Previous post Next post →